Wall Street climbs on Boeing, Trump's reopening plan

By Medha Singh and Akanksha Rana (Reuters) - Wall Street bounced on Friday, boosted by a surge in Boeing shares, with President Donald Trump's plan to reopen the economy and hopes of a potential drug by Gilead to treat COVID-19 helping sentiment. Shares of the U.S. planemaker soared 12.3% on plans to restart commercial jet production in Washington state after halting operations last month due to the coronavirus pandemic.

Reuters April 18, 2020 00:05:22 IST
Wall Street climbs on Boeing, Trump's reopening plan

Wall Street climbs on Boeing Trumps reopening plan

By Medha Singh and Akanksha Rana

(Reuters) - Wall Street bounced on Friday, boosted by a surge in Boeing shares, with President Donald Trump's plan to reopen the economy and hopes of a potential drug by Gilead to treat COVID-19 helping sentiment.

Shares of the U.S. planemaker soared 12.3% on plans to restart commercial jet production in Washington state after halting operations last month due to the coronavirus pandemic.

The S&P 500 has now regained about 30% from a March trough and is set for its third weekly gain in four following a raft of global stimulus and on hopes that statewide lockdowns would be eased as the outbreak showed signs of ebbing.

However, the index is still about 19% away from reclaiming its all-time high and analysts have warned of a deep economic slump as a halt in business activity puts millions of Americans out of work.

"Expectations are very low and every time you get a bit of good news - even if there is skepticism attached to the Gilead drug and to the timeline of opening up different regions - it's still better than anyone would have expected," said Thomas Hayes, managing member at Great Hill Capital LLC in New York.

Some U.S. states on Friday were expected to announce timetables for lifting restrictions, a day after President Donald Trump outlined guidelines for a phased reopening of the devastated U.S. economy.

Gilead Sciences Inc surged 8.1% following a report that patients with severe symptoms of the disease had responded positively to its experimental drug, remdesivir.

With no treatments or vaccines currently approved for the coronavirus, the news lifted global equity markets, but Gilead said the totality of the data from the trial needed to be analyzed and it expected to report results from a study in severe COVID-19 patients at the end of April.

"The anecdotal evidence out of Gilead's Chicago trials for remdesivir are just that: anecdotal, even though they are part of a Phase 3 trial," said Peter Cecchini, managing director and chief market strategist at Cantor Fitzgerald in New York.

Bank stocks recovered after four straight days of losses, which were triggered by lenders reporting several billion dollars in reserves to cover potential loan defaults. Financial stocks were the top boost to the S&P 500.

The risk-on sentiment pushed Wall Street's fear gauge below 40 and sent safe-haven gold down almost 2%.

At 12:48 p.m. ET, the Dow Jones Industrial Average was up 447.62 points, or 1.90%, at 23,985.30 and the S&P 500 was up 49.54 points, or 1.77%, at 2,849.09. The Nasdaq Composite was up 58.27 points, or 0.68%, at 8,590.63.

Amazon.com Inc and Netflix Inc eased slightly from record highs after surging this week on strong demand for online streaming services and home delivery of goods.

Apple Inc fell 1.9% as Goldman Sachs downgraded the stock on expectations of a 36% drop in iPhone shipments during the third quarter due to coronavirus-related lockdowns.

Advancing issues outnumbered decliners by a 5.83-to-1 ratio on the NYSE and by a 4.02-to-1 ratio on the Nasdaq.

The S&P index recorded eight new 52-week highs and no new lows, while the Nasdaq recorded 26 new highs and seven new lows.

(Reporting by Medha Singh and Akanksha Rana in Bengaluru; Editing by Sagarika Jaisinghani, Shounak Dasgupta and Anil D'Silva)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.